Competition Questions
- How broad is differentiation “plasticity” for hematopoietic stem cells?
- What sources of non-hematopoietic stem cells are promising for leukemia/lymphoma treatment?
- What are the main expectations and pitfalls in gene therapy, experimental and clinical?
- What biological criteria of transplant quality should be used in clinical settings?
- What sources/types of stem cells are applicable for regenerative therapy?
- Cell therapy in non-malignant diseases (e.g., myocardial, autoimmune disorders): what biological effects are curative?
- What biological factors mediate immunotherapeutic effects in leukemia/lymphoma?
- Modifying microenvironment: an auxiliary tool in leukemia treatment?
- Graft-versus-host disease: are there optimal ways for its prediction/prevention?
- What infections are worth of detection in transplant patients?
- Minimal residual disease: what biological markers are preferable?
- Life Quality assessment in transplanted patients: a guide for optimal treatment, or individual prognosis?
- Open access Internet sources in stem cell biology and medicine: is their current use optimal?
- What are the optimal types of current regulations in cell therapy (detailed guidelines, centralized licensing bodies etc.)?
